Altered Protein Expression in Gestational Diabetes Mellitus Placentas Provides Insight into Insulin Resistance and Coagulation/Fibrinolysis Pathways

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Liu, Bin ^a   Xu, Yun ^c   Voss, Courtney ^d   Qiu, Fang hua ^a   Zhao, Ming zhe ^a   Liu, Yong dong ^a   Nie, Jing ^b   Wang, Zi lian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; GLUCOSE; LIPOCORTIN 2; LIPOCORTIN 5; MESSENGER RNA; PLACENTA PROTEIN; RAS PROTEIN;

ADULT; APOPTOSIS; ARTICLE; BLOOD CLOTTING; CALCIUM BINDING; CLINICAL ARTICLE; FEMALE; FIBRINOLYSIS; GLUCOSE TOLERANCE; HUMAN; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PLACENTA VILLUS; PREGNANCY DIABETES MELLITUS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; BLOOD COAGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FIBRINOLYSIS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; PLACENTA; PREGNANCY; PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84866102216     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044701     Document Type: Article

References (43)

1. Diagnosis and classification of diabetes mellitus. Diabetes Care 29Suppl 1: S43-48.
2. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, et al. (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361: 1339-1348.
3. Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M, (2007) Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 30: 878-883.
4. Kim C, Newton KM, Knopp RH, (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25: 1862-1868.
5. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J, (2003) Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 133: 1674S-1683S.
6. Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, et al. (2000) Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 49: 2208-2211.
7. Desoye G, Hauguel-de Mouzon S, (2007) The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 30 (Suppl 2):: S120-126.
8. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, et al. (2002) TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51: 2207-2213.
9. Leach L, Taylor A, Sciota F, (2009) Vascular dysfunction in the diabetic placenta: causes and consequences. J Anat 215: 69-76.
10. Leach L, (2011) Placental vascular dysfunction in diabetic pregnancies: intimations of fetal cardiovascular disease? Microcirculation 18: 263-269.
11. Hiden U, Lang I, Ghaffari-Tabrizi N, Gauster M, Lang U, et al. (2009) Insulin action on the human placental endothelium in normal and diabetic pregnancy. Curr Vasc Pharmacol 7: 460-466.
12. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S, (2003) Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 52: 2951-2958.
13. Enquobahrie DA, Williams MA, Qiu C, Meller M, Sorensen TK (2009) Global placental gene expression in gestational diabetes mellitus. Am J Obstet Gynecol 200: 206 e201-213.
14. Mine K, Katayama A, Matsumura T, Nishino T, Kuwabara Y, et al. (2007) Proteome analysis of human placentae: pre-eclampsia versus normal pregnancy. Placenta 28: 676-687.
15. Pessin JE, Saltiel AR, (2000) Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106: 165-169.
16. Di Guglielmo GM, Drake PG, Baass PC, Authier F, Posner BI, et al. (1998) Insulin receptor internalization and signalling. Mol Cell Biochem 182: 59-63.
17. Mayran N, Parton RG, Gruenberg J, (2003) Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells. EMBO J 22: 3242-3253.
18. Morel E, Gruenberg J, (2009) Annexin A2 binding to endosomes and functions in endosomal transport are regulated by tyrosine 23 phosphorylation. J Biol Chem 284: 1604-1611.
19. Emans N, Gorvel JP, Walter C, Gerke V, Kellner R, et al. (1993) Annexin II is a major component of fusogenic endosomal vesicles. J Cell Biol 120: 1357-1369.
20. Biener Y, Feinstein R, Mayak M, Kaburagi Y, Kadowaki T, et al. (1996) Annexin II is a novel player in insulin signal transduction. Possible association between annexin II phosphorylation and insulin receptor internalization. J Biol Chem 271: 29489-29496.
21. Ogihara T, Isobe T, Ichimura T, Taoka M, Funaki M, et al. (1997) 14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain. J Biol Chem 272: 25267-25274.
22. Kosaki A, Yamada K, Suga J, Otaka A, Kuzuya H, (1998) 14-3-3beta protein associates with insulin receptor substrate 1 and decreases insulin-stimulated phosphatidylinositol 3′-kinase activity in 3T3L1 adipocytes. J Biol Chem 273: 940-944.
23. Xiang X, Yuan M, Song Y, Ruderman N, Wen R, et al. (2002) 14-3-3 facilitates insulin-stimulated intracellular trafficking of insulin receptor substrate 1. Mol Endocrinol 16: 552-562.
24. Pedersen J (1977) The pregnant diabetic and her newborn: problems and management: Munksgaard Copenhagen.
25. Catalano PM, Hauguel-De Mouzon S, (2011) Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 204: 479-487.
26. Takata K, Hirano H, (1997) Mechanism of glucose transport across the human and rat placental barrier: a review. Microsc Res Tech 38: 145-152.
27. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, et al. (2005) Harrison's principles of internal medicine: McGraw-Hill.
28. Engelke H, Lippok S, Dorn I, Netz RR, Radler JO, (2011) FVIII binding to PS membranes differs in the activated and non-activated form and can be shielded by annexin A5. J Phys Chem B 115: 12963-12970.
29. Grundmann U, Abel KJ, Bohn H, Lobermann H, Lottspeich F, et al. (1988) Characterization of cDNA encoding human placental anticoagulant protein (PP4): homology with the lipocortin family. Proc Natl Acad Sci U S A 85: 3708-3712.
30. Thiagarajan P, Tait JF, (1990) Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem 265: 17420-17423.
31. Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, et al. (2000) Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 283: 221-228.
32. Hu CD, Kariya K, Okada T, Qi X, Song C, et al. (1999) Effect of phosphorylation on activities of Rap1A to interact with Raf-1 and to suppress Ras-dependent Raf-1 activation. J Biol Chem 274: 48-51.
33. Lyons TJ, (1993) Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 71: 26B-31B.
34. Tames FJ, Mackness MI, Arrol S, Laing I, Durrington PN, (1992) Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects. Atherosclerosis 93: 237-244.
35. Zhang J, Ren S, Sun D, Shen GX, (1998) Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells. Arterioscler Thromb Vasc Biol 18: 1140-1148.
36. Ren S, Lee H, Hu L, Lu L, Shen GX, (2002) Impact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells. J Clin Endocrinol Metab 87: 286-291.
37. Sangle GV, Zhao R, Mizuno TM, Shen GX, (2010) Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells. Endocrinology 151: 4455-4466.
38. Aso Y, (2007) Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. Front Biosci 12: 2957-2966.
39. Falcone DJ, Borth W, Khan KM, Hajjar KA, (2001) Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II. Blood 97: 777-784.
40. Ishii H, Yoshida M, Hajjar KA, Tanaka A, Yasukochi Y, et al. (2001) Potential role of recombinant annexin II in diabetic vascular injury. Ann N Y Acad Sci 947: 308-311.
41. Lei H, Romeo G, Kazlauskas A, (2004) Heat shock protein 90alpha-dependent translocation of annexin II to the surface of endothelial cells modulates plasmin activity in the diabetic rat aorta. Circ Res 94: 902-909.
42. Person MD, Shen J, Traner A, Hensley SC, Lo HH, et al. (2006) Protein fragment domains identified using 2D gel electrophoresis/MALDI-TOF. Journal of biomolecular techniques: JBT 17: 145.
43. Zhu K, Zhao J, Lubman DM, Miller FR, Barder TJ, (2005) Protein pI shifts due to posttranslational modifications in the separation and characterization of proteins. Anal Chem 77: 2745-2755.